Eternal Group Secures Pre-Seed Funding for Health and Performance Platform

Eternal Group Ltd, a health and performance software company with a UK base in Wembley and headquarters in San Francisco, has raised £10.1k in a pre-seed funding round. The transaction, filed on March 16, 2026, values the business at £20k post-money.

Incorporated in October 2025, Eternal Group operates in the health technology sector. The company develops a high performance care model designed by scientists, doctors, and athletes. The platform aims to help lifelong athletes and health enthusiasts adapt their training routines to their specific life stages, promoting fuller and healthier lives. The business currently employs 69 people. As an early stage entity, key financial metrics such as revenue and profit or loss are not yet publicly available.

The pre-seed round was allotted and filed simultaneously. The company secured £10.1k, bringing its estimated post-money valuation to £20k. Specific investor names were not disclosed in the regulatory filings. As a recently incorporated entity, this marks the first recorded funding activity for the business in the UK.

This funding event occurs within a highly active UK health technology landscape. The UK health tech sector has seen a surge in software platforms focused on preventative care and longevity. Investors have increasingly backed platforms that utilize data to personalize health routines. While the broader UK venture capital market has experienced fluctuating investment volumes over the past twenty four months, specialized health and wellness software remains a resilient category. Early stage health tech companies continue to attract significant capital, with UK startups in the sector raising over £2.5bn in recent years.

However, the size of this specific transaction is unusual for the sector. UK pre-seed rounds typically average between £250k and £500k. The notably smaller initial capital injection of £10.1k, combined with the £20k valuation, suggests this allotment may reflect an initial structural setup, founder share issuance, or a minor capital injection to establish its UK operations rather than a traditional institutional venture capital raise.

Eternal Group enters this market with a distinct focus on the intersection of elite sports science and general wellness. By targeting both dedicated health enthusiasts and elite performers, the company addresses a growing consumer demand for professional grade health management tools. The business continues to focus on pioneering its high performance care model, bridging the gap between elite athletic training and everyday health optimization.